Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
2024 Style: The It-Things You Want in Your Closet - 2Iran slams UN nuclear watchdog for failing to condemn Bushehr attacks
- 3Eight wounded, cars catch fire in central Israel following strike from Iranian cluster munition
- 4Well known Tea Brands for Each Tea Sweetheart
- 5Dominating the Remote Work Way of life: Individual Systems
- Tech for Learning: Online Courses and Instructive Apparatuses
- The Magnificence of Extraordinariness: Presenting Valuable Adornments and Gemstones
- The Best Computer games Ever
- Instructions to Warmly greet Certainty and Appeal
- Best Disney Palace: Which One Catches Your Creative mind?
- Airbnb Unveils Airport Pickup Service Across 125 Cities in Global Expansion
- Rediscovering Imagination in Adulthood: Individual Creative Excursions
- Merz visit highlights new strategic, and strained, Germany-Israel bond
- Top Pastry: What's Your Sweet Treat of Decision?
